FR2966733B1 - NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH - Google Patents

NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH

Info

Publication number
FR2966733B1
FR2966733B1 FR1004261A FR1004261A FR2966733B1 FR 2966733 B1 FR2966733 B1 FR 2966733B1 FR 1004261 A FR1004261 A FR 1004261A FR 1004261 A FR1004261 A FR 1004261A FR 2966733 B1 FR2966733 B1 FR 2966733B1
Authority
FR
France
Prior art keywords
new therapeutic
therapeutic strategies
signaling path
hedgehog signaling
strategies involving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1004261A
Other languages
French (fr)
Other versions
FR2966733A1 (en
Inventor
Veteau Isabelle Mus
Michel Bidet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1004261A priority Critical patent/FR2966733B1/en
Priority to PCT/FR2011/000558 priority patent/WO2012056120A1/en
Publication of FR2966733A1 publication Critical patent/FR2966733A1/en
Application granted granted Critical
Publication of FR2966733B1 publication Critical patent/FR2966733B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1004261A 2010-10-29 2010-10-29 NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH Expired - Fee Related FR2966733B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1004261A FR2966733B1 (en) 2010-10-29 2010-10-29 NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH
PCT/FR2011/000558 WO2012056120A1 (en) 2010-10-29 2011-10-18 Use of a modulator of the patched protein for regulating intracellular cholesterol concentration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1004261A FR2966733B1 (en) 2010-10-29 2010-10-29 NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH

Publications (2)

Publication Number Publication Date
FR2966733A1 FR2966733A1 (en) 2012-05-04
FR2966733B1 true FR2966733B1 (en) 2012-12-14

Family

ID=43981692

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1004261A Expired - Fee Related FR2966733B1 (en) 2010-10-29 2010-10-29 NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH

Country Status (2)

Country Link
FR (1) FR2966733B1 (en)
WO (1) WO2012056120A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1917897A (en) * 2003-12-19 2007-02-21 柯里斯公司 Composition and methods for modulating cns activity

Also Published As

Publication number Publication date
FR2966733A1 (en) 2012-05-04
WO2012056120A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
SMT201500291B (en) NEW ANTIMALARIC AGENTS
FR2957244B1 (en) ARTHRODESE IMPLANT
BR112013013311A2 (en) cytotoxicity-inducing therapeutic agent
BR302012005339S1 (en) "POINT SETUP".
BR112012000568A2 (en) multiple sclerosis treatment with laquinimod
BR112012028549A2 (en) Toothbrush
SMT201200009B (en) Pirfenidone therapy that avoids fluvoxamine
BR112013013584A2 (en) endoscope and method
BR112013011850A2 (en) Toothbrush
DK2823810T3 (en) Amphoteric liposomes comprising iminolipids
FR2956074B1 (en) TRAIN TRAIN
FR2973218B1 (en) OSTEOSYNTHESIS PLATE.
CU23987B1 (en) MEDICAL EQUIPMENT
DE112011103919A5 (en) endoscope
BR112013008074A2 (en) pharmaceutical combinations
SMT201600041B (en) THERAPEUTIC AGENTS 713
DK2429856T3 (en) Track Event
FR2986542B1 (en) ANCHOR PIT
IT1398997B1 (en) GIOSTRA FOR CAVALLI TRAINING
FR2990456B1 (en) PREFABRICATED STAIRWALK
FR2968685B1 (en) FIRE TERMINAL
IT1399653B1 (en) FESTONATRICE EQUIPMENT.
FR2966733B1 (en) NEW THERAPEUTIC STRATEGIES INVOLVING THE HEDGEHOG SIGNALING PATH
FR2961007B1 (en) "BLOCK SWITCH".
ES1073355Y (en) NOT INCLUDED OR PROVIDED

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140630